Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in acute myocardial infarction and particularities in …

BS Tudurachi, L Anghel, A Tudurachi… - International Journal of …, 2023 - mdpi.com
Cardiovascular disease, particularly coronary artery disease (CAD), remains a predominant
cause of mortality globally. Factors such as atherosclerosis and inflammation play significant …

Prognostic value of systemic immune‐inflammation index in CAD patients: Systematic review and meta‐analyses

Z Zhao, X Zhang, T Sun, X Huang, M Ma… - European Journal of …, 2024 - Wiley Online Library
Background Systemic immune‐inflammation index (SII) is a novel inflammatory marker
based on neutrophils, platelets and lymphocytes counts, which has potential prognostic …

Systemic immune-inflammation index and C-reactive protein/albumin ratio could predict acute stent thrombosis and high SYNTAX score in acute coronary syndrome

MK Akboga, IH Inanc, C Sabanoglu, A Akdi… - …, 2023 - journals.sagepub.com
Acute stent thrombosis (AST) is associated with increased morbidity and mortality. The main
aim of this study was to evaluate the prognostic value of the systemic immune-inflammation …

Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry

J Luo, X Qin, X Zhang, Y Zhang, F Yuan, W Shi… - Cardiovascular …, 2024 - Springer
Background It is well-known that systemic inflammation plays a crucial role in the
pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune …

Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction–a post-hoc analysis of the EMMY trial

M Benedikt, H Mangge, F Aziz, P Curcic… - Cardiovascular …, 2023 - Springer
Background SGTL2-inhibitors are a cornerstone in the treatment of heart failure, but data on
patients with acute myocardial infarction (AMI) is limited. The EMMY trial was the first to …

Association of red blood cell distribution width, systemic-immune-inflammation index and poor cardiovascular outcomes in patients with newly diagnosed …

F Uzun, A Güner, H Pusuroglu, AR Demir… - Clinical and …, 2022 - Taylor & Francis
Background Red cell distribution width (RDW) and the systemic immune-inflammation index
(SII) have been extensively studied as predictors of morbidity and mortality in several …

Systemic immune-inflammation index (SII) may be an effective indicator in predicting the left ventricular hypertrophy for patients diagnosed with hypertension

O Karayiğit, SG Nurkoç, MC Çelik - Journal of human hypertension, 2023 - nature.com
The development of left ventricular hypertrophy (LVH) induced by hypertension is
considered a poor prognosis for patients. Similarly, high values of the systemic immune …

[HTML][HTML] Is the first-trimester systemic immune-inflammation index associated with preeclampsia?

MFC Akdulum, E Demirdağ, Sİ Arık, S Safarova… - Cureus, 2023 - ncbi.nlm.nih.gov
Objective: Preeclampsia (PE) is a serious and common pregnancy issue. There is a
systemic inflammation in PE and it is accompanied by increased oxidative stress, but the …

Special issue on ischemic heart disease

P Lancellotti, H Petitjean, A Nchimi, B Cosyns - Acta Cardiologica, 2023 - Taylor & Francis
This issue of Acta Cardiologica is devoted to ischaemic heart disease (IHD). Cardiovascular
disease (CVD), primarily IHD, itself usually referring to coronary artery disease (CAD), is the …

Correlations Between Acute Coronary Syndrome and Novel Inflammatory Markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index …

A Tuzimek, EA Dziedzic, J Beck… - Journal of Inflammation …, 2024 - Taylor & Francis
Purpose Type 2 diabetes mellitus (DM) is a recognized independent risk factor for both
chronic coronary syndrome (CCS) and its complication, acute coronary syndrome (ACS) …